For PD-L1, a disintegrin and metalloproteinase 10 (ADAM10) and ADAM17 cleave the PD-L1 ectodomain from tumor cells to generate soluble PD-L1 (sPD-L1) and modulate the TME. Here, SPDL1 is linked to neoplasm.